Patent details
EP4047018 Title: TETRAVALENT BISPECIFIC ANTIBODY AGAINST PD-1 AND VEGF, PREPARATION METHOD THEREFOR, AND USE THEREOF
Basic Information
- Publication number:
- EP4047018
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP221529316
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TETRAVALENT BISPECIFIC ANTIBODY AGAINST PD-1 AND VEGF, PREPARATION METHOD THEREFOR, AND USE THEREOF
- French Title of Invention:
- ANTICORPS BISPÉCIFIQUE TÉTRAVALENT CONTRE PD-1 ET VEGF, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
- German Title of Invention:
- TETRAVALENTER BISPEZIFISCHER ANTIKÖRPER GEGEN PD-1 UND VEGF, VERFAHREN ZU SEINER HERSTELLUNG UND SEINE VERWENDUNG
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 12/01/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 23/01/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 13/12/2023
- Unitary Effect Registration Date:
- 23/01/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 19/04/2021
- Grant date:
- 13/12/2023
- EP Publication Date:
- 24/08/2022
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 13/12/2023
- EP B1 Publication Date:
- 13/12/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 19/04/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 06/12/2023
- Name:
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Address:
- No. 399 Libing Road, Pilot Free Trade Zone CHINA (SHANGHAI) Shanghai 201203, China (CN)
Inventor
1
- Name:
- ZHU, Zhenping
- Address:
- China (CN)
2
- Name:
- ZHAO, Jie
- Address:
- China (CN)
3
- Name:
- HUANG, Haomin
- Address:
- China (CN)
Priority
- Priority Number:
- 202010357134
- Priority Date:
- 29/04/2020
- Priority Country:
- China (CN)
Classification
- IPC classification:
- C07K 16/22; A61P 11/06; C07K 16/32; C07K 16/46; A61P 17/00; A61P 17/06; A61P 27/02; A61P 29/00; A61P 35/00; A61P 35/02; A61P 37/02; A61K 39/00; A61P 19/02; C07K 16/28;
Publication
European Patent Bulletin
1
- Issue number:
- 202350
- Publication date:
- 13/12/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202408
- Publication date:
- 21/02/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202408
- Publication date:
- 21/02/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|